United States Biotechnology & Medical Research

Osiris Therapeutics Inc (OSIR)

Track

Ticker: OSIR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 4 Jun 2015
Value US$4,808,011.24 | Price 483.45 | Shares 9,237 (-13.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-06-08 2015-06-04 B Purchase LAW GREGORY IVAN

Principal Accounting Officer

Officer
9,237 -13.0%
483.45
US$4,808,011 		9,237 -13.0% 483.45 US$4,808,011
2015-05-29 2015-05-27 S Sale JACOBY PHILIP R JR

Chief Financial Officer

Officer
49,413 +35.2%
144.73
US$874,613 		49,413 +35.2% 144.73 US$874,613
2014-05-30 2014-05-29 S Sale Neumayer Matthew Paul

Principal Accounting Officer

Officer
14,889 +22.3%
128.92
US$832,796 		14,889 +22.3% 128.92 US$832,796
2014-05-29 2014-05-27 S Sale Neumayer Matthew Paul

Principal Accounting Officer

Officer
3,750 -39.0%
16.10
US$60,375 		3,750 -39.0% 16.10 US$60,375
2014-05-23 2014-05-21 S Sale JACOBY PHILIP R JR

Chief Financial Officer

Officer
15,947 -56.1%
15.43
US$245,998 		15,947 -56.1% 15.43 US$245,998
2014-03-17 2014-03-14 S Sale Williams Michelle LeRoux

Chief Scientific Officer

Officer
11,934 -100.0%
13.91
US$166,009 		11,934 -100.0% 13.91 US$166,009
2014-03-17 2014-03-13 S Sale Williams Michelle LeRoux

Chief Scientific Officer

Officer
50,000 -100.0%
14.14
US$706,925 		50,000 -100.0% 14.14 US$706,925
2013-11-26 2013-11-25 S Sale JACOBY PHILIP R JR

Chief Financial Officer

Officer
18,372 -59.5%
15.99
US$293,680 		18,372 -59.5% 15.99 US$293,680
2013-11-18 2013-11-15 S Sale Williams Michelle LeRoux

Chief Scientific Officer

Officer
24,500 -100.0%
15.50
US$379,632 		24,500 -100.0% 15.50 US$379,632
2013-08-20 2013-08-20 S Sale Neumayer Matthew Paul

Principal Accounting Officer

Officer
11,375 -100.0%
19.75
US$224,656 		11,375 -100.0% 19.75 US$224,656
2012-12-11 2012-12-11 S Sale Williams Michelle LeRoux

Chief Scientific Officer

Officer
520 -100.0%
9.31
US$4,840 		520 -100.0% 9.31 US$4,840
2012-12-11 2012-12-11 B Purchase Williams Michelle LeRoux

Chief Scientific Officer

Officer
520 +inf%
0.40
US$208 		520 +inf% 0.40 US$208
2012-12-10 2012-12-10 S Sale VENTURETEC INC Large shareholder
50,000 -1.2%
9.52
US$476,000 		50,000 -1.2% 9.52 US$476,000
2012-12-10 2012-12-10 S Sale FRIEDLI PETER Non-Executive Director Large shareholder
50,000 -1.1%
9.52
US$476,000 		50,000 -1.1% 9.52 US$476,000
2012-11-16 2012-11-15 S Sale FRIEDLI PETER Non-Executive Director Large shareholder
625 -0.0%
9.34
US$5,838 		625 -0.0% 9.34 US$5,838
2011-06-06 2011-06-06 B Purchase BARNHILL GREGORY HURD Non-Executive Director
25,000 +47.7%
7.07
US$176,695 		25,000 +47.7% 7.07 US$176,695
2011-06-06 2011-06-03 B Purchase BARNHILL GREGORY HURD Non-Executive Director
25,000 +91.2%
7.20
US$179,965 		25,000 +91.2% 7.20 US$179,965
2008-12-10 2008-12-08 S Sale Carmitchel Harry E

Chief Operating Officer

Officer
7,000 -9.1%
19.46
US$136,220 		7,000 -9.1% 19.46 US$136,220
2008-12-05 2008-12-03 S Sale Carmitchel Harry E

Chief Operating Officer

Officer
5,000 -6.1%
20.35
US$101,750 		5,000 -6.1% 20.35 US$101,750
2008-11-14 2008-11-14 B Purchase FRIEDLI PETER Non-Executive Director Large shareholder
205,423 +2.1%
12.17
US$2,499,998 		205,423 +2.1% 12.17 US$2,499,998
2008-11-14 2008-11-14 B Purchase VENTURETEC INC Large shareholder
189,681 +4.8%
13.18
US$2,499,996 		189,681 +4.8% 13.18 US$2,499,996
2008-07-07 2008-07-03 B Purchase FENDER EARL R
37,500 +inf%
6.84
US$256,500 		37,500 +inf% 6.84 US$256,500
2007-12-20 2007-12-19 B Purchase FRIEDLI PETER Non-Executive Director Large shareholder
662,746 +7.2%
13.00
US$8,615,698 		662,746 +7.2% 13.00 US$8,615,698
2007-12-20 2007-12-19 B Purchase FRIEDLI PETER Non-Executive Director Large shareholder
100,000 +1.1%
12.37
US$1,237,000 		100,000 +1.1% 12.37 US$1,237,000
2007-12-20 2007-12-19 B Purchase VENTURETEC INC Large shareholder
100,000 +2.6%
12.37
US$1,237,000 		100,000 +2.6% 12.37 US$1,237,000
2007-06-08 2007-06-06 B Purchase FRIEDLI PETER Non-Executive Director Large shareholder
1,230,229 +15.7%
11.38
US$14,000,006 		1,230,229 +15.7% 11.38 US$14,000,006
2007-06-08 2007-06-06 B Purchase VENTURETEC INC Large shareholder
263,620 +7.3%
11.38
US$2,999,996 		263,620 +7.3% 11.38 US$2,999,996
Explore more

More insider trading research around Osiris Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America